HOUSTON--(BUSINESS WIRE)--Introgen Technical Services, Inc. (ITS) today announced that the company has expanded its contract manufacturing and service business by signing manufacturing agreements to produce biological materials for two key new customers: Advantagene, Inc. and the H. Lee Moffitt Cancer Center. Additionally, ITS has expanded its ongoing collaborative relationship with Oncolys BioPharma, Inc. through completion of additional GMP production services for that company. Aggregate proceeds to ITS from these contracts total more that $1 million. Under the terms of these new agreements, ITS will produce GMP-grade biologics for use in oncology applications including:
